COVID ‐19 and Pregnancy: Key Findings

Read full text Summarise with VIRAT
Authors: Gabrielle Gimenes Lima, Ana Flávia Segati, Giovanna Santos Oliveira, Nicoly Simões de Melo, Tulio Nakazato da Cunha, Elizabeth De Gaspari
Cited by: 0
References: 34

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Pregnant individuals were prioritised for COVID-19 research due to concerns about increased susceptibility and limited clinical trial data. This narrative review synthesises evidence on maternal infection, immunological adaptations, placental susceptibility, and antibody transfer following maternal SARS-CoV-2 vaccination. Symptomatic COVID-19 during pregnancy increases risks of severe outcomes, whereas vertical transmission remains rare. Placental pathology is characterised mainly by maternal vascular malperfusion and inflammation, with limited evidence of direct viral infection. Maternal vaccination-particularly with mRNA vaccines-induces robust IgG responses with efficient transplacental and lactational transfer, conferring passive neonatal protection. Key uncertainties include optimal vaccine timing, durability of neonatal immunity, and variant-specific responses. Strengthening standardised research and ensuring inclusion of pregnant individuals is essential for global maternal health policy.

Fields of Study & Subjects

COVID-19 Impact on Reproduction SARS-CoV-2 and COVID-19 Research COVID-19 Clinical Research Studies

Publication details

Journal / source
Scandinavian Journal of Immunology
Volume
103
Issue
4
Pages
e70109–e70109
Publication date
25 March 2026
Language
EN